138 related articles for article (PubMed ID: 28649486)
1. Constrictive pericarditis-induced shunting through a PFO: Persistence despite pericardiectomy.
Schuiteman E; Verrill T; Mina N; Dalal B
Respir Med Case Rep; 2017; 22():28-30. PubMed ID: 28649486
[TBL] [Abstract][Full Text] [Related]
2. Flow-driven right-to-left cardiac shunting in a patient with carcinoid heart disease and patent foramen ovale without elevated right atrial pressure: a case report and literature review.
Dherange P; Telles N; Modi K
Eur Heart J Case Rep; 2020 Dec; 4(6):1-5. PubMed ID: 33442599
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous balloon catheter closure of a patent foramen ovale in a patient with pulmonary disease, profound hypoxemia, and normal right heart pressures.
Allan JJ; Marinelli C; Dellsperger KC; Winniford MD
Clin Cardiol; 1997 Mar; 20(3):307-9. PubMed ID: 9068923
[TBL] [Abstract][Full Text] [Related]
4. Tricuspid-regurgitation-mediated flow-driven right-to-left cardiac shunting caused systemic hypoxemia in a patient with patent foramen ovale without elevated right atrial pressure.
Teng P; Zhao H; Yuan S; Lou G; Wu S
Heliyon; 2023 Feb; 9(2):e13556. PubMed ID: 36873149
[TBL] [Abstract][Full Text] [Related]
5. Acute-Hypoxemia-Induced Right-To-Left Shunting in the Presence of Patent Foramen Ovale.
Noori MAM; Rushdy A; Shah KK; Shamoon F; Naser M
Cureus; 2021 Jul; 13(7):e16138. PubMed ID: 34262827
[TBL] [Abstract][Full Text] [Related]
6. An Unusual Case of Hypoxia: A Case of Right-to-Left Interatrial Shunting in a Patient With a Patent Foramen Ovale and Normal Pulmonary Pressure.
Abdelsayed N; Duff R; Faris M
Cureus; 2022 Mar; 14(3):e22998. PubMed ID: 35415050
[TBL] [Abstract][Full Text] [Related]
7. [Patent foramen ovale and hypoxaemia with or without elevated right heart pressures].
Bancal C; Arnoult F; Krapf L; Bonay M
Rev Mal Respir; 2011 Oct; 28(8):967-77. PubMed ID: 22099402
[TBL] [Abstract][Full Text] [Related]
8. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal supine hypoxaemia with hyperthyroidism and atrial fibrillation: a case report of a diagnostic challenge.
Liu LY; Reddy YNV; Niven AS; Hu TY; Larson KF; Mulpuru SK; Cullen MW
Eur Heart J Case Rep; 2022 Jun; 6(6):ytac214. PubMed ID: 35734629
[TBL] [Abstract][Full Text] [Related]
10. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome.
Mojadidi MK; Gevorgyan R; Noureddin N; Tobis JM
Catheter Cardiovasc Interv; 2015 Oct; 86(4):701-7. PubMed ID: 26063336
[TBL] [Abstract][Full Text] [Related]
11. Is surgical closure of patent foramen ovale the gold standard for treating interatrial shunts? An echocardiographic follow-up study.
Schneider B; Bauer R
J Am Soc Echocardiogr; 2005 Dec; 18(12):1385-91. PubMed ID: 16376771
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Outcomes of Positive Bubble Contrast Study Results After Transcatheter Closure of a Patent Foramen Ovale.
Shah AH; Osten M; Benson L; Alnasser S; Bach Y; Vishwanath R; Van De Bruaene A; Shulman H; Navaranjan J; Khan R; Horlick E
JACC Cardiovasc Interv; 2018 Jun; 11(11):1095-1104. PubMed ID: 29880106
[TBL] [Abstract][Full Text] [Related]
13. Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia.
Dong B; Lu Y; He S; Li B; Li Y; Lai Q; Li W; Ji S; Chen Y; Dai L; Chen L
MedComm (2020); 2023 Aug; 4(4):e334. PubMed ID: 37576864
[TBL] [Abstract][Full Text] [Related]
14. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers.
Deng W; McMullin D; Inglessis-Azuaje I; Locascio JJ; Palacios IF; Buonanno FS; Lo EH; Ning M
Neurology; 2021 Jul; 97(2):e203-e214. PubMed ID: 33986139
[TBL] [Abstract][Full Text] [Related]
15. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
[TBL] [Abstract][Full Text] [Related]
16. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
17. Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study.
Hammerstingl C; Bauriedel B; Stüsser C; Momcilovic D; Tuleta I; Nickenig G; Skowasch D
Eur J Med Res; 2011 Jan; 16(1):13-9. PubMed ID: 21345765
[TBL] [Abstract][Full Text] [Related]
18. Risk mitigation in divers with persistent (patent) foramen ovale.
Wilmshurst P
Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
[TBL] [Abstract][Full Text] [Related]
19. Patent Foramen Ovale and Hypoxemia.
Mojadidi MK; Ruiz JC; Chertoff J; Zaman MO; Elgendy IY; Mahmoud AN; Al-Ani M; Elgendy AY; Patel NK; Shantha G; Tobis JM; Meier B
Cardiol Rev; 2019; 27(1):34-40. PubMed ID: 29570476
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical emboli following a pulmonary embolus in the presence of a patent foramen ovale.
Najib K; Heckle M; Goubran S; Mehta R; Goswami R; Khouzam RN
Ann Transl Med; 2018 Jan; 6(1):21. PubMed ID: 29404367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
